In vivo generation of CAR myeloid cells through erythrocyte-mediated mRNA delivery for cancer immunotherapy

Tumor-Induced Splenic Remodeling: Mechanisms of Systemic Immunosuppression and Emerging Therapeutic Opportunities

Eythrocyte-anti-PD1 conjugates in persons with advanced solid tumors resistant to anti-PD-1/PD-L1: preclinical characterization and results of a phase I trial

Single-dose erythrocyte–uricase conjugate with immunosuppressants induces durable immune tolerance to overcome uricase immunogenicity and treat gout

Single coadministration of erythrocyte-uricase conjugate and immunosuppressant induces durable immune tolerance for gout therapy

DNA remnants in red blood cells enable early detection of cancer

BRAF inhibitors enhance erythropoiesis and treat anemia through paradoxical activation of MAPK signaling

Lenalidomide-induced pure red cell aplasia is associated with elevated expression of MHC-I molecules on erythrocytes

MED26-enriched condensates drive erythropoiesis through modulating transcription pausing